The therapeutic potential of GLP-1R and its agonists has reshaped approaches to managing type 2 diabetes mellitus (T2DM), cardiovascular diseases, obesity, and even neurodegenerative conditions. This evidence concerns the gene GLP1R and obesity disorder.